Despair fuels hope

Despair fuels hope ...
Contract Pharma

Ardena Highlights the Biopharma Industry’s Shift Toward Integrated Support

Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...

Guide to Avoid Pitfalls in Primary Cell Procurement Released! Cloud-Clone Corp. Unveils Buying Guide for Novice Researchers to Boost Research Efficiency

KATY, TX / ACCESS Newswire / July 6, 2026 / In the fields of life sciences and pharmaceutical R&D, primary cells retain ...
Technology Networks

Cellpose, StarDist, and the Deep Learning Cell Segmentation Revolution

Compare deep learning cell segmentation tools Cellpose and StarDist: how each works, how they differ by imaging type, and ...

Comprehensive Insights on Minimal Residual Disease Pipeline: Key Players and Emerging Therapies by 2026

The Minimal Residual Disease pipeline presents key opportunities for drug development, highlighting promising therapies in various trial phases. Companies like AmMax Bio and Genentech leverage ...
Technology Networks

Automated Quality Control: Accelerating Lot Release with PCR Assays

Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...
IGN

Dune: Part 2 Ending Explained - How It Sets Up a Third Movie

Warning: This article contains full spoilers for Dune: Part 2! And if you're just here to find out whether there's a post-credits scene at the end, there isn't one. Denis Villeneuve's latest movie has ...
Drug Target Review

From R&D to QC: building a single analytical strategy for cell and gene therapies

From early research to quality control, maintaining analytical continuity is no easy task. Could a single sequencing workflow help simplify analytical assessment?
Healthcare Asia Magazine

Body fluid analysis market to hit $3.65b on neurological and cancer demand

The global body fluid analysis market will rise from $2.62b in 2026 to $3.65b in 2031, at a compound annual growth rate of ...